EUS fine-needle pancreatic core biopsy can determine eligibility for tumor-agnostic immunotherapy

por Gleeson, Ferga C., Levy, Michael J., Roden, Anja C., Boardman, Lisa A., Sinicrope, Frank A., McWilliams, Robert R., Zhang, Lizhi
Publicado 2018

Factors influencing receptivity to future screening options for pancreatic cancer in those with and without pancreatic cancer family history

por Breitkopf, Carmen Radecki, Sinicrope, Pamela S, Rabe, Kari G, Brockman, Tabetha A, Patten, Christi A, McWilliams, Robert R, Ehlers, Shawna, Petersen, Gloria M
Publicado 2012

The role of microbiome in pancreatic cancer

por Li, Jenny Jing, Zhu, Mojun, Kashyap, Purna C., Chia, Nicholas, Tran, Nguyen H., McWilliams, Robert R., Bekaii-Saab, Tanios S., Ma, Wen Wee
Publicado 2021

Genetic variations associated with gemcitabine treatment outcome in pancreatic cancer

por Li, Liang, Zhang, Jian-Wei, Jenkins, Gregory, Xie, Fang, Carlson, Erin E., Fridley, Brooke L., Bamlet, William R., Petersen, Gloria M., McWilliams, Robert R., Wang, Liewei
Publicado 2016

PREVALENCE OF GERMLINE MUTATIONS IN CANCER GENES AMONG PANCREATIC CANCER PATIENTS WITH POSITIVE FAMILY HISTORY

por Chaffee, Kari G., Oberg, Ann L., McWilliams, Robert R., Majithia, Neil, Allen, Brian A., Kidd, John, Singh, Nanda, Hartman, Anne-Renee, Wenstrup, Richard J., Petersen, Gloria M.
Publicado 2017

BRAF V600 Mutation Detection in Plasma Cell-Free DNA: NCCTG N0879 (Alliance)

por Slostad, Jessica A., Liu, Minetta C., Allred, Jacob B., Erickson, Lori A., Rumilla, Kandelaria M., Block, Matthew S., Keppen, Michael, King, David, Markovic, Svetomir N., McWilliams, Robert R.
Publicado 2021

Association Between Survival and Metastatic Site in Mismatch Repair–Deficient Metastatic Colorectal Cancer Treated With First-line Pembrolizumab

por Saberzadeh-Ardestani, Bahar, Jones, Jeremy C., Hubbard, Joleen M., McWilliams, Robert R., Halfdanarson, Thorvardur R., Shi, Qian, Sonbol, Mohamad Bassam, Ticku, Jonathan, Jin, Zhaohui, Sinicrope, Frank A.
Publicado 2023

Chemo-immunotherapy combination after PD-1 inhibitor failure improves clinical outcomes in metastatic melanoma patients

por Vera Aguilera, Jesus, Paludo, Jonas, McWilliams, Robert R., Zhang, Henan, Li, Ying, Kumar, Anagha B., Failing, Jarrett, Kottschade, Lisa A., Block, Matthew S., Markovic, Svetomir N., Dong, Haidong, Dronca, Roxana S., Yan, Yiyi
Publicado 2020

Phase II Trial of Trifluridine/Tipiracil Plus Irinotecan in Patients with Advanced, Refractory Biliary Tract Carcinoma

por Tella, Sri Harsha, Foster, Nathan, Qian, Shi, Nguyen, Tran, Borad, Mitesh J, McWilliams, Robert R, Alberts, Steven R, Wee Ma, Wen, Chakrabarti, Sakti, Fruth, Briant, Wessling, Jaclynn, Hartgers, Mindy, Washburn, Leslie, Fernandez-Zapico, Martin E, Hogenson, Tara L, Pitot, Henry, Jin, Zhaohui, Mahipal, Amit
Publicado 2023

Assessment of clinical outcomes with immune checkpoint inhibitor therapy in melanoma patients with CDKN2A and TP53 pathogenic mutations

por DeLeon, Thomas T., Almquist, Daniel R., Kipp, Benjamin R., Langlais, Blake T., Mangold, Aaron, Winters, Jennifer L., Kosiorek, Heidi E., Joseph, Richard W., Dronca, Roxana S., Block, Matthew S., McWilliams, Robert R., Kottschade, Lisa A., Rumilla, Kandelaria M., Voss, Jesse S., Seetharam, Mahesh, Sekulic, Aleksandar, Markovic, Svetomir N., Bryce, Alan H.
Publicado 2020

BRCA1, BRCA2, PALB2, and CDKN2A Mutations in Familial Pancreatic Cancer (FPC): A PACGENE Study

por Zhen, David B., Rabe, Kari G., Gallinger, Steven, Syngal, Sapna, Schwartz, Ann G., Goggins, Michael G., Hruban, Ralph H., Cote, Michele L., McWilliams, Robert R., Roberts, Nicholas J., Cannon-Albright, Lisa A., Li, Donghui, Moyes, Kelsey, Wenstrup, Richard J., Hartman, Anne-Renee, Seminara, Daniela, Klein, Alison P., Petersen, Gloria M.
Publicado 2014

Neoadjuvant Chemotherapy Switch in Borderline Resectable/Locally Advanced Pancreatic Cancer

por Alva-Ruiz, Roberto, Yohanathan, Lavanya, Yonkus, Jennifer A., Abdelrahman, Amro M., Gregory, Lindsey A., Halfdanarson, Thorvadur R., Mahipal, Amit, McWilliams, Robert R., Ma, Wen Wee, Hallemeier, Christopher L., Graham, Rondell P., Grotz, Travis E., Smoot, Rory L., Cleary, Sean P., Nagorney, David M., Kendrick, Michael L., Truty, Mark J.
Publicado 2021

Phase II trial of the IDO pathway inhibitor indoximod plus pembrolizumab for the treatment of patients with advanced melanoma

por Zakharia, Yousef, McWilliams, Robert R, Rixe, Olivier, Drabick, Joseph, Shaheen, Montaser F, Grossmann, Kenneth F, Kolhe, Ravindra, Pacholczyk, Rafal, Sadek, Ramses, Tennant, Lucinda L, Smith, Christopher M, Kennedy, Eugene P, Link Jr, Charles J, Vahanian, Nicholas N, Yu, Jiayi, Shen, Steven S, Brincks, Erik L, Rossi, Gabriela R, Munn, David, Milhem, Mohammed
Publicado 2021

Predicting Adverse Pathologic Features and Clinical Outcomes of Resectable Pancreas Cancer With Preoperative CA 19-9

por Kowalchuk, Roman O., Lester, Scott C., Graham, Rondell P., Harmsen, William S., Zhang, Lizhi, Halfdanarson, Thorvardur R., Smoot, Rory L., Gits, Hunter C., Ma, Wen Wee, Owen, Dawn, Mahipal, Amit, Miller, Robert C., Wittich, Michelle A. Neben, Cleary, Sean P., McWilliams, Robert R., Haddock, Michael G., Hallemeier, Christopher L., Truty, Mark J., Merrell, Kenneth W.
Publicado 2021

A phase I oncolytic virus trial with vesicular stomatitis virus expressing human interferon beta and tyrosinase related protein 1 administered intratumorally and intravenously in u...

por Smith, Katherine E. R., Peng, Kah-Whye, Pulido, Jose S., Weisbrod, Adam J., Strand, Carrie A., Allred, Jacob B., Newsom, Alysha N., Zhang, Lianwen, Packiriswamy, Nandakumar, Kottke, Timothy, Tonne, Jason M., Moore, Madelyn, Montane, Heather N., Kottschade, Lisa A., McWilliams, Robert R., Dudek, Arkadiusz Z., Yan, Yiyi, Dimou, Anastasios, Markovic, Svetomir N., Federspiel, Mark J., Vile, Richard G., Dronca, Roxana S., Block, Matthew S.
Publicado 2023

The vitamin D receptor gene as a determinant of survival in pancreatic cancer patients: Genomic analysis and experimental validation

por Innocenti, Federico, Owzar, Kouros, Jiang, Chen, Etheridge, Amy S., Gordân, Raluca, Sibley, Alexander B., Mulkey, Flora, Niedzwiecki, Donna, Glubb, Dylan, Neel, Nicole, Talamonti, Mark S., Bentrem, David J., Seiser, Eric, Yeh, Jen Jen, Van Loon, Katherine, McLeod, Howard, Ratain, Mark J., Kindler, Hedy L., Venook, Alan P., Nakamura, Yusuke, Kubo, Michiaki, Petersen, Gloria M., Bamlet, William R., McWilliams, Robert R.
Publicado 2018

Experience with precision genomics and tumor board, indicates frequent target identification, but barriers to delivery

por Bryce, Alan H., Egan, Jan B., Borad, Mitesh J., Stewart, A. Keith, Nowakowski, Grzegorz S., Chanan-Khan, Asher, Patnaik, Mrinal M., Ansell, Stephen M., Banck, Michaela S., Robinson, Steven I., Mansfield, Aaron S., Klee, Eric W., Oliver, Gavin R., McCormick, Jennifer B., Huneke, Norine E., Tagtow, Colleen M., Jenkins, Robert B., Rumilla, Kandelaria M., Kerr, Sarah E., Kocher, Jean-Pierre A., Beck, Scott A., Fernandez-Zapico, Martin E., Farrugia, Gianrico, Lazaridis, Konstantinos N., McWilliams, Robert R.
Publicado 2017

Comprehensive Genomic Analysis of Metastatic Mucinous Urethral Adenocarcinoma Guides Precision Oncology Treatment: Targetable EGFR Amplification Leading to Successful Treatment Wit...

por Bryce, Alan H., Borad, Mitesh J., Egan, Jan B., Condjella, Rachel M., Liang, Winnie S., Fonseca, Rafael, McCullough, Ann E., Hunt, Katherine S., Ritacca, Nicole R., Barrett, Michael T., Patel, Maitray D., Young, Scott W., Silva, Alvin C., Ho, Thai H., Halfdanarson, Thorvardur R., Stanton, Melissa L., Cheville, John, Swanson, Scott, Schneider, Daniel E., McWilliams, Robert R., Baker, Angela, Aldrich, Jessica, Kurdoglu, Ahmet, Izatt, Tyler, Christoforides, Alexis, Cherni, Irene, Nasser, Sara, Reiman, Rebecca, Cuyugan, Lori, McDonald, Jacquelyn, Adkins, Jonathan, Mastrian, Stephen D., Von Hoff, Daniel D., Craig, David W., Stewart, A. Keith, Carpten, John D.
Publicado 2016

Clinical Implementation of Integrated Genomic Profiling in Patients with Advanced Cancers

por Borad, Mitesh J., Egan, Jan B., Condjella, Rachel M., Liang, Winnie S., Fonseca, Rafael, Ritacca, Nicole R., McCullough, Ann E., Barrett, Michael T., Hunt, Katherine S., Champion, Mia D., Patel, Maitray D., Young, Scott W., Silva, Alvin C., Ho, Thai H., Halfdanarson, Thorvardur R., McWilliams, Robert R., Lazaridis, Konstantinos N., Ramanathan, Ramesh K., Baker, Angela, Aldrich, Jessica, Kurdoglu, Ahmet, Izatt, Tyler, Christoforides, Alexis, Cherni, Irene, Nasser, Sara, Reiman, Rebecca, Cuyugan, Lori, McDonald, Jacquelyn, Adkins, Jonathan, Mastrian, Stephen D., Valdez, Riccardo, Jaroszewski, Dawn E., Von Hoff, Daniel D., Craig, David W., Stewart, A. Keith, Carpten, John D., Bryce, Alan H.
Publicado 2016

Integrated Genomic Characterization Reveals Novel, Therapeutically Relevant Drug Targets in FGFR and EGFR Pathways in Sporadic Intrahepatic Cholangiocarcinoma

por Borad, Mitesh J., Champion, Mia D., Egan, Jan B., Liang, Winnie S., Fonseca, Rafael, Bryce, Alan H., McCullough, Ann E., Barrett, Michael T., Hunt, Katherine, Patel, Maitray D., Young, Scott W., Collins, Joseph M., Silva, Alvin C., Condjella, Rachel M., Block, Matthew, McWilliams, Robert R., Lazaridis, Konstantinos N., Klee, Eric W., Bible, Keith C., Harris, Pamela, Oliver, Gavin R., Bhavsar, Jaysheel D., Nair, Asha A., Middha, Sumit, Asmann, Yan, Kocher, Jean-Pierre, Schahl, Kimberly, Kipp, Benjamin R., Barr Fritcher, Emily G., Baker, Angela, Aldrich, Jessica, Kurdoglu, Ahmet, Izatt, Tyler, Christoforides, Alexis, Cherni, Irene, Nasser, Sara, Reiman, Rebecca, Phillips, Lori, McDonald, Jackie, Adkins, Jonathan, Mastrian, Stephen D., Placek, Pamela, Watanabe, Aprill T., LoBello, Janine, Han, Haiyong, Von Hoff, Daniel, Craig, David W., Stewart, A. Keith, Carpten, John D.
Publicado 2014